CAS 361440-67-7 Purity> 98.5% (HPLC) Factory

Kufotokozera Kwachidule:

(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester

CAS: 361440-67-7

Kuyera:> 98.5% (HPLC)

Maonekedwe: Ufa Woyera

Wapakati wa API (CAS: 361442-04-8)

E-Mail: alvin@ruifuchem.com


Tsatanetsatane wa Zamalonda

Zogwirizana nazo

Zolemba Zamalonda

Kufotokozera:

Chemical Properties:

Dzina la Chemical (1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo[3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester
Mawu ofanana ndi mawu N-Boc-L-cis-4,5-Methanoprolineamide;N-Boc-cis-4,5-Methano-L-Prolinamide;tert-Butyl (1S,3S,5S)-3-Carbamoyl-2-Azabicyclo[3.1.0]hexane-2-Carboxylate
Nambala ya CAS 361440-67-7
Nambala ya CAT RF-PI1990
Stock Status Mu Stock, Kupanga Kukula Mpaka Matani
Molecular Formula C11H18N2O3
Kulemera kwa Maselo 226.27
Boiling Point 388.9±21.0℃
Kuchulukana 1.228
Mtundu Ruifu Chemical

Zofotokozera:

Kanthu Zofotokozera
Maonekedwe Ufa Woyera
Kuyera / Kusanthula Njira > 98.5% (HPLC)
Kutaya pa Kuyanika <0.50%
Zotsalira pa Ignition <0.20%
Zidetso za Munthu Payekha <1.00%
Zonse Zonyansa <1.50%
Test Standard Enterprise Standard
Kugwiritsa ntchito Wapakati wa API (CAS: 361442-04-8)

Phukusi & Kusungira:

Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi lamulo la kasitomala

Mkhalidwe Wosungira:Sungani muzitsulo zosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi

Ubwino:

1

FAQ:

Ntchito:

(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo[3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester (CAS: 361440-67-7) ndi wapakatikati wa API (CAS: 361442 -04-8).(CAS: 361442-04-8) ndi oral hypoglycemic (anti-diabetic drug) a dipeptidyl peptidase-4 (DPP-4) inhibitor class of drug.Kukula koyambirira kunali kokha ndi Bristol-Myers Squibb;mu 2007 AstraZeneca adalumikizana ndi Bristol-Myers Squibb kuti agwirizane kupanga gulu lomaliza ndikuchita nawo malonda a mankhwalawa.Mu June 2008, adalengezedwa kuti Onglyza adzakhala dzina lamalonda lomwe lidzagulitsidwa.API (CAS: 361442-04-8) imagwiritsidwa ntchito ngati monotherapy kapena kuphatikiza ndi mankhwala ena pochiza matenda amtundu wa 2.Imatengeka mwachangu pambuyo pakamwa ndipo imakhala ndi mbiri ya pharmacokinetic yogwirizana ndi mlingo umodzi patsiku.Imagwira ntchito poletsa kuwonongeka kwa GLP-l.GLP-I ndi mahomoni omwe amapangidwa mwachilengedwe m'matumbo atatha kudya.

Lembani uthenga wanu apa ndikutumiza kwa ife